What Happened?
Malvern, PA-based VenatoRx Appointed James Murphy as Chief Financial Officer
Date of management change: November 15, 2014
Malvern, PA-based VenatoRx Appointed James Murphy as Chief Financial Officer
VenatoRx Pharmaceuticals is a private pharmaceutical company dedicated to the discovery and development of novel anti-infective agents to address the threat of antibiotic resistance. The company name, VenatoRx (ven-a-TOR-ex), derives from the latin word “venator”, meaning hunter and “Rx”, the medical symbol for drugs. The pursuit, or “hunt”, for new drugs is the core mission of the company. Located northwest of Philadelphia in Malvern, PA, the company was founded in 2010 by Drs. Burns, Xerri, and Pevear. Since founding, the company has received multiple awards from the NIH, including 5 Small Business Innovative Research (SBIR) grants and an R01 grant. The company has also been awarded a contract from the NIH and funding from the Wellcome Trust to advance the company’s product candidates.
James Murphy is Chief Financial Officer at VenatoRx. Previously, James held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Bakich Barbara, Gonzalez Marissa, Canaday Tyrone, Moore James, Nelson Connia, Spinelli Black Robin, Broome Lisa, Lane Rich, McKenny Wanda, O'Dowd Kevin, Moore Stephen
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.